Lack of Patient Compliance in Real-World Practice Negatively Affects Sustained Viral Response Rates to Direct Acting Agent Therapy for Hepatitis C
- 20 August 2018
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 63 (12) , 3228-3232
Abstract
To assess the true efficacy of direct acting antiviral (DAA) therapy in real-world clinical practice, taking into account those patients that do not complete therapy or the necessary follow-up to establish sustained viral response (SVR).Keywords
This publication has 9 references indexed in Scilit:
- Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis CJournal of Hepatology, 2018
- The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort‐studyHepatology, 2017
- High hepatitis C cure rates among black and nonblack human immunodeficiency virus–infected adults in an urban centerHepatology, 2017
- Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infectionHepatology, 2017
- Mortality in hepatitis C patients who achieve a sustained viral response compared to the general populationJournal of Hepatology, 2017
- Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic ResponseGastroenterology, 2016
- Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care SystemGastroenterology, 2016
- Best strategies for globalHCVeradicationLiver International, 2013
- A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C VirusClinical Gastroenterology and Hepatology, 2010